{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:02:15Z","timestamp":1792803735940,"version":"4.5.0"},"reference-count":168,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["GM57242"],"award-info":[{"award-number":["GM57242"]}]},{"name":"Friedman Family Cancer Research Foundation","award":["GM57242"],"award-info":[{"award-number":["GM57242"]}],"id":[{"id":"https:\/\/ror.org\/052nngb38","id-type":"ROR","asserted-by":"crossref"}]},{"name":"New York State Department of Health Empire State Stem Cell Trust","award":["GM57242"],"award-info":[{"award-number":["GM57242"]}],"id":[{"id":"https:\/\/ror.org\/04hf5kq57","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Charlotte P. Graver Fund","award":["GM57242"],"award-info":[{"award-number":["GM57242"]}]},{"name":"Edith Dickstein and Sylvan Kessler Estate Foundation","award":["GM57242"],"award-info":[{"award-number":["GM57242"]}]},{"name":"Grace A. Miller Foundation for Pancreatic Cancer Research","award":["GM57242"],"award-info":[{"award-number":["GM57242"]}],"id":[{"id":"https:\/\/ror.org\/05dekb105","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>A heterogenous population of inflammatory elements, other immune and nonimmune cells and cancer-associated fibroblasts (CAFs) are evident in solid malignancies where they coexist with the growing tumor mass. In highly desmoplastic malignancies, CAFs are the prominent mesenchymal cell type in the tumor microenvironment (TME), where their presence and abundance signal a poor prognosis. CAFs play a major role in the progression of various cancers by remodeling the supporting stroma into a dense, fibrotic matrix while secreting factors that promote the maintenance of cancer stem-like characteristics, tumor cell survival, aggressive growth and metastasis and reduced sensitivity to chemotherapeutics. Tumors with high stromal fibrotic signatures are more likely to be associated with drug resistance and eventual relapse. Identifying the molecular underpinnings for such multidirectional crosstalk among the various normal and neoplastic cell types in the TME may provide new targets and novel opportunities for therapeutic intervention. This review highlights recent concepts regarding the complexity of CAF biology in cholangiocarcinoma, a highly desmoplastic cancer. The discussion focuses on CAF heterogeneity, functionality in drug resistance, contributions to a progressively fibrotic tumor stroma, the involved signaling pathways and the participating genes.<\/jats:p>","DOI":"10.3390\/cells13100796","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T11:00:10Z","timestamp":1715079610000},"page":"796","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment"],"prefix":"10.3390","volume":"13","author":[{"given":"Ralf-Peter","family":"Czekay","sequence":"first","affiliation":[{"name":"Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig E.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Basri","family":"Aydin","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Samarakoon","sequence":"additional","affiliation":[{"name":"Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nusret Bekir","family":"Subasi","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7005-6278","authenticated-orcid":false,"given":"Hwajeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pathology & Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Regenerative & Cancer Cell Biology, Albany Medical College, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1242\/dmm.010561","article-title":"The challenge of cholangocarcinoma: Dissecting the molecular mechanisms of an insidious cancer","volume":"6","author":"Zabron","year":"2013","journal-title":"Dis. Models Mech."},{"key":"ref_2","first-page":"6","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2012","journal-title":"Nat. Rev. (Dis. Primers)"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3892\/ijo.2023.5585","article-title":"Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (review)","volume":"63","author":"Yang","year":"2023","journal-title":"Int. J. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2407-11-78","article-title":"Genome-wide expression patterns associated with oncogenesis and sarcomatous transdifferentation of cholangiocarcinoma","volume":"11","author":"Seol","year":"2011","journal-title":"BMS Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.5858\/arpa.2022-0537-RA","article-title":"Cholangiocarcinoma: Pathologic and molecular classification in the era of precision medicine","volume":"148","author":"Gopal","year":"2023","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.1038\/s41598-021-93250-4","article-title":"A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients","volume":"11","author":"Li","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.jcmgh.2022.02.014","article-title":"Single-cell transcriptomic architecture unraveling the complexity of tumor heterogeneity in distal cholangiocarcinoma","volume":"13","author":"Li","year":"2022","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-2007-1007302","article-title":"Recent advances in the management of cholangiocarcinomas","volume":"14","author":"Vauthey","year":"1994","journal-title":"Semin. Liver Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/ags3.12691","article-title":"Current progress in perioperative chemotherapy for biliary tract cancer","volume":"7","author":"Ioka","year":"2023","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Pavicevic, S., Reichelt, S., Uluk, D., Lurje, I., Engelmann, C., Modest, D.P., Pelzer, U., Krenzien, F., Raschzok, N., and Benzing, C. (2022). Prognostic and predictive molecular markers in cholangiocarcinoma. Cancers, 14.","DOI":"10.3390\/cancers14041026"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"154565","DOI":"10.1016\/j.prp.2023.154565","article-title":"Small but mighty: How microRNAs drive the deadly progression of cholangiocarcinoma","volume":"247","author":"Jalil","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/liv.14093","article-title":"Anatomical histomorphological and molecular classification of cholangiocarcinoma","volume":"39","author":"Kendall","year":"2019","journal-title":"Liver Int."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Sadot, E., Simpson, A.L., Do, R.K.G., Gonen, M., Shia, J., Allen, P.J., D\u2019Angelica, M.I., DeMatteo, R.P., Kingham, T.P., and Jarnagin, W.R. (2015). Cholangiocarcinoma: Correlation between molecular profiling and imaging phenotypes. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0132953"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Chen, C., Nelson, L.J., Avila, M.A., and Cubero, F.J. (2019). Mitogen-activated protein kinases (MAPKs) and cholangiocarcinoma: The missing link. Cells, 8.","DOI":"10.3390\/cells8101172"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: The next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"S158","DOI":"10.1016\/j.actatropica.2010.07.006","article-title":"Opisthorchiasis and opisthorchis-associated cholangiocarcinoma in Thailand and Laos","volume":"120","author":"Sripa","year":"2011","journal-title":"Acta Trop."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-pathol-052016-100322","article-title":"The role of cancer-associated fibroblasts and fibrosis in liver cancer","volume":"12","author":"Affo","year":"2017","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kawamura, E., Matsubara, T., and Kawada, N. (2023). New era of immune-based therapy in intrahepatic cholangiocarcinoma. Cancers, 15.","DOI":"10.3390\/cancers15153993"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Sato, K., Baiocchi, L., Kennedy, L., Zhang, W., Ekser, B., Glaser, S., Francis, H., and Alpini, G. (2021). Current advances in basic and translation research of cholangiocarcinoma. Cancers, 13.","DOI":"10.3390\/cancers13133307"},{"key":"ref_22","first-page":"329","article-title":"Desmoplastic breast carcinoma as a source of human myofibroblasts","volume":"115","author":"Barsky","year":"1984","journal-title":"Am. J. Pathol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"dmm029447","DOI":"10.1242\/dmm.029447","article-title":"A peek into cancer-associated fibroblasts: Origins, functions and translational impact","volume":"11","author":"LeBleu","year":"2018","journal-title":"Dis. Model Mech."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1152\/physrev.00048.2019","article-title":"Diversity and biology of cancer-associated fibroblasts","volume":"101","author":"Biffi","year":"2021","journal-title":"Physiol. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Liu, T., Zhou, L., Li, D., Andl, T., and Zhang, Y. (2019). Cancer-associated fibroblasts build and secure the tumor microenvironment. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00060"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: Targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","article-title":"Stroma cells in the tumor microenvironment","volume":"1060","author":"Denton","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10555-012-9415-3","article-title":"Stromal cells in tumor microenvironment and breast cancer","volume":"32","author":"Mao","year":"2013","journal-title":"Cancer Metastasis Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kim, I., Choi, S., Yoo, S., Lee, M., and Kim, I.-S. (2022). Cancer associated fibroblasts in the hypoxic tumor microenvironment. Cancers, 14.","DOI":"10.3390\/cancers14143321"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jcmgh.2023.01.006","article-title":"Cancer-associated fibroblasts in hepatocellular carcinoma and cholangiocarcinoma","volume":"15","author":"Ying","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7707","DOI":"10.1158\/0008-5472.CAN-08-1132","article-title":"Pancreatic stellate cells and pancreatic cancer cells: An unholy alliance","volume":"68","author":"Vonlaufen","year":"2008","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/jcp.30582","article-title":"Hepatic stellate cells in the injured liver: Perspectives beyond hepatic fibrosis","volume":"237","author":"Ezhilarasan","year":"2022","journal-title":"J. Cell. Physiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1158\/2159-8290.CD-21-0601","article-title":"Mesenchymal lineage heterogeneity underlies nonredundant functions of pancreatic cancer-associated fibroblasts","volume":"12","author":"Helms","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","article-title":"Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma","volume":"73","author":"Zhang","year":"2020","journal-title":"J. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MOG.0000000000000609","article-title":"Cancer-associated fibroblasts in cholangiocarcinoma","volume":"36","author":"Vaquero","year":"2020","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"7348","DOI":"10.1245\/s10434-023-13867-9","article-title":"Postoperative prognosis according to pathologic categorization of desmoplastic reaction in patients with extrahepatic cholangiocarcinoma","volume":"30","author":"Yoshida","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_37","first-page":"957","article-title":"Alpha-smooth muscle actin-positive fibroblasts promote biliary cell proliferation and correlate with poor survival in cholangiocarcinoma","volume":"21","author":"Chuaysri","year":"2009","journal-title":"Oncol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Gundlach, J.-P., Kerber, J., Hendricks, A., Bernsmeier, A., Halske, C., Roder, C., Becker, T., Rocken, C., Braun, R., and Sebens, S. (2022). Paracrine interaction of cholangiocellular carcinoma with cancer-associated fibroblasts and Schwann cells impact cell migration. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102785"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Vita, F., Olaizola, I., Amato, F., Rae, C., Marco, S., Banales, J.M., and Craconi, C. (2023). Heterogeneity of cholangiocarcinoma immune biology. Cells, 12.","DOI":"10.3390\/cells12060846"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e004892","DOI":"10.1136\/jitc-2022-004892","article-title":"Multimodule characterization of immune subgroups in intrahepatic cholangiocarcinoma reveals distinct therapeutic vulnerabilities","volume":"10","author":"Lin","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1158\/2159-8290.CD-12-0107","article-title":"CD36 represssion activates a multicellular stromal program shared by high mammographic density and tumor tissues","volume":"2","author":"DeFilippis","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1158\/2159-8290.CD-12-0348","article-title":"Desmoplasia: A response or a niche?","volume":"2","author":"DeClerck","year":"2012","journal-title":"Cancer Discov."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"Il1-induced jak\/stat signaling is antagonized by TGF\u03b2 to shape caf heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer associated fibroblasts: From basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","article-title":"Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations","volume":"39","author":"Affo","year":"2021","journal-title":"Cancer Cell"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Knipper, K.K., Lyu, S.I., Quaas, A., Bruns, C.J., and Schmidt, T. (2023). Cancer-associated fibroblast heterogeneity and its influence on the extracellular matrix and the tumor microenvironment. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241713482"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Nallanthighal, S., Heiserman, J.P., and Cheon, D.-J. (2019). The role of the extracellular matrix in cancer stemness. Front. Cell Dev. Biol., 7.","DOI":"10.3389\/fcell.2019.00086"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Joshi, R.S., Kanugula, S.S., Sudhir, S., Pereira, M.P., Jain, S., and Aghi, M.K. (2021). The role of cancer-associated fibroblasts in tumor progression. Cancers, 13.","DOI":"10.3390\/cancers13061399"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Czekay, R.-P., Cheon, D.-J., Samarakoon, R., Kutz, S.M., and Higgins, P.J. (2022). Cancer-associated fibroblasts: Mechanisms of tumor progression and novel therapeutic targets. Cancers, 14.","DOI":"10.3390\/cancers14051231"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: Recent advances and future perspectives","volume":"43","author":"Fang","year":"2023","journal-title":"Cancer Commun."},{"key":"ref_51","first-page":"1503","article-title":"Fibroblast heterogeneity in the cancer wound","volume":"21","author":"Elyada","year":"2014","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13073-022-01127-6","article-title":"Extracellular matrix profiles determine risk and prognosis of the squamous cell carcinoma subtype of non-small cell lung carcinoma","volume":"14","author":"Parker","year":"2022","journal-title":"Genome Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"668731","DOI":"10.3389\/fonc.2021.668731","article-title":"Cancer-associated fibroblasts and tumor-associated macrophages in cancer and cancer immunotherapy","volume":"11","author":"Raskov","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_55","first-page":"1889","article-title":"Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells","volume":"9","author":"Huang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Ganguly, D., Chandra, R., Karalis, J., Teke, M., Aguilera, T., Maddipati, R., Wachsmann, M.B., Ghersi, D., Siravegna, G., and Zeh, H.J. (2020). Cancer-associated fibroblasts: Versatile players in the tumor microenvironment. Cancers, 12.","DOI":"10.3390\/cancers12092652"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Shi, X., Young, C.D., Zhou, H., and Wang, X.-J. (2020). Transforming growth factor-\u03b2 signaling in fibrotic diseases and cancer-associated fibroblasts. Biomolecules, 10.","DOI":"10.3390\/biom10121666"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Noguchi, S., Saito, A., and Nagase, T. (2018). Yap\/taz signaling as a molecular link between fibrosis and cancer. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113674"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fmed.2015.00059","article-title":"Signaling in fibrosis: TGF-\u03b2, wnt, and yap\/taz converge","volume":"2","author":"Piersma","year":"2015","journal-title":"Front. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1080\/15384101.2019.1642069","article-title":"Interactions between TGF-\u03b2 type i receptor and hypoxia-inducible factor-a mediates a synergistic crosstalk leading to poor prognosis for patients with clear cell renal cell carcinoma","volume":"18","author":"Mallikarjuna","year":"2019","journal-title":"Cell Cycle"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Arima, Y., Matsueda, S., and Saya, H. (2023). Significance of cancer-associated fibroblasts in the interactions of cancer cells with the tumor microenvironment of heterogeneous tumor tissue. Cancers, 15.","DOI":"10.3390\/cancers15092536"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e21725","DOI":"10.1096\/fj.202002652RR","article-title":"PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-\u03b2-receptor signaling","volume":"35","author":"Gifford","year":"2021","journal-title":"FASEB J."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Papoutsoglou, P., Louis, C., and Coulouarn, C. (2019). Transforming growth factor beta (TGF\u03b2) signaling pathway in cholangiocarcinoma. Cells, 8.","DOI":"10.3390\/cells8090960"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/hep4.1142","article-title":"A novel transforming growth factor beta-induced long noncoding RNA promotes an inflammatory microenvironment in human intrahepatic cholangiocarcinoma","volume":"2","author":"Merdrignac","year":"2018","journal-title":"Hepatol. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1213891","DOI":"10.3389\/fphar.2023.1213891","article-title":"Identification and validation of SEPINE1 as a prognostic and immunological biomarker in pan-cancer and in ccRCC","volume":"14","author":"Li","year":"2023","journal-title":"Front. Pharmacol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"963209","DOI":"10.1155\/2009\/963209","article-title":"PAI-1 regulates the invasive phenotype in human cutaneous squamous cell carcinoma","volume":"2009","author":"Freytag","year":"2009","journal-title":"J. Oncol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13046-023-02714-0","article-title":"Cancer associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells","volume":"42","author":"Wei","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/s41374-020-00512-2","article-title":"PAI-1 derived from cancer-associated fibroblasts in esophageal squamous cell carcinoma promotes the invasion of cancer cells and the migration of macrophages","volume":"101","author":"Sakamoto","year":"2021","journal-title":"Lab. Investig."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Cartier-Michaud, A., Malo, M., Charriere-Bertrand, C., Gadea, G., Anguille, C., Supiramaniam, A., Lesne, A., Delaplace, F., Hutzler, G., and Roux, P. (2012). Matrix-bound PAI-1 supports cell blebbing via RhoA\/ROCK1 signaling. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0032204"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"10596","DOI":"10.1096\/fj.201900943R","article-title":"TGF-\u03b21-p53 cooperativity regulates a profibrotic genomic program in the kidney: Molecular mechanisms and clinical implications","volume":"33","author":"Higgins","year":"2019","journal-title":"FASEB J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1096\/fj.201700722R","article-title":"Deregulation of hippo-taz pathway during renal injury confers a fibrotic maladaptive phenotype","volume":"32","author":"Anorga","year":"2018","journal-title":"FASEB J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cellsig.2008.11.015","article-title":"Function of Akt\/PKB signaling to cell motility, invasion and the tumor stroma in cancer","volume":"21","author":"Chin","year":"2009","journal-title":"Cell. Signal."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10620-010-1352-9","article-title":"p53 status and its prognostic role in extrahepatic bile duct cancer: A meta-analysis of published studies","volume":"56","author":"Wang","year":"2011","journal-title":"Dig. Dic. Sci."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/modpathol.3880231","article-title":"Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis","volume":"13","author":"Bartheja","year":"2000","journal-title":"Mod. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1478-3231.2005.01106.x","article-title":"p53 mutations in human cholangiocarcinoma: A review","volume":"25","author":"Khan","year":"2005","journal-title":"Liver Int."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.cellsig.2014.02.017","article-title":"Redox control of p53 in the transcriptional regulation of TGF-\u03b21 target genes through SMAD cooperativity","volume":"26","author":"Overstreet","year":"2014","journal-title":"Cell. Signal."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/cdd.2017.48","article-title":"\u0394133p53 represses p53-inducible senescence genes and enhances the generation of human induced pluripotent stem cells","volume":"24","author":"Horikawa","year":"2017","journal-title":"Cell Death Differ."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.cellsig.2013.07.007","article-title":"Induction of renal fibrotic genes by TGF-\u03b21 requires EGFR activation, p53 and reactive oxygen species","volume":"25","author":"Samarakoon","year":"2013","journal-title":"Cell. Signal."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.11.005","article-title":"TBG-\u03b21\/p53 signaling in renal fibrogenesis","volume":"43","author":"Higgins","year":"2018","journal-title":"Cell. Signal."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/ncb1448","article-title":"Plasminogen activator inibitor-1 is a critical downstream target of p53 in the induction of replicative senescence","volume":"8","author":"Kortlever","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"ref_81","first-page":"2351","article-title":"\u0394Np63\u03b1 and Tap63\u03b1 regulate transcription of genes with distinct biological functions in cancer and development","volume":"63","author":"Wu","year":"2003","journal-title":"Cancer Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1038\/sj.onc.1210561","article-title":"p63 consensus DNA-binding site: Identification, analysis and application into a p63MH algorithm","volume":"26","author":"Perez","year":"2007","journal-title":"Oncogene"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/onc.2016.112","article-title":"TNF-\u03b1 modulates genome-wide redistribution of \u0394Np63\u03b1\/Tap73 and NF-\u03baB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer","volume":"35","author":"Si","year":"2016","journal-title":"Oncogene"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3892\/ijo.2013.1818","article-title":"Ratiodisrution of the \u0394133p53 and Tap53 isoform equilibrium correlates with poor clinical outcome in intrahepatic cholangiocarcinoma","volume":"42","author":"Nutthasirikul","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through Yap and Taz drives fibroblast activation and fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.1038\/s41598-019-51343-1","article-title":"Hypoxia-inducible factor-1\u03b1 is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy","volume":"9","author":"Bessho","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"C277","DOI":"10.1152\/ajpcell.00205.2016","article-title":"TAZ activation drives fibroblast spheroid growth, expression of profibrotic paracrine signals, and context-dependent ECM gene expression","volume":"312","author":"Jorgenson","year":"2017","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3892\/ijo.2020.5153","article-title":"Crosstalk between Yap and TGF\u03b2 regulates SERPINE1 expression in mesenchymal lung cancer cells","volume":"58","author":"Kong","year":"2021","journal-title":"Int. J. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Higgins, C.E., Tang, J., Higgins, S.P., Gifford, C.C., Mian, B.M., Jones, D.M., Zhang, W., Costello, A., Conti, D.J., and Samarakoon, R. (2021). The genomic response to TGF-\u03b21 dictates failed repair and progression of fibrotic disease in the obstructed kidney. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.678524"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12964-020-00634-6","article-title":"Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator inhibitor-1 (PAI-1) expression in hepatocarcinogenesis","volume":"18","author":"Marquard","year":"2020","journal-title":"Cell Commun. Signal."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: A signalling hub of the tumour microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fonc.2014.00039","article-title":"Biotensegrity of the extracellular matrix: Physiology, dynamic mechanical balance, and implications in oncology and mechanotherapy","volume":"4","author":"Tadeo","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of heterogeneous cancer-associated fibroblasts: The molecular pathology of activated signaling pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Tsai, P.-J., Lai, Y.-H., Manne, R.K., Tsai, Y.-S., Sarbassov, D., and Lin, H.-K. (2022). Akt: A key transducer in cancer. J. Biomed. Sci., 29.","DOI":"10.1186\/s12929-022-00860-9"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jnci\/djs648","article-title":"PKB\/Akt-dependent regulation of cell motility","volume":"105","author":"Xue","year":"2013","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Singh, S.P., Paschke, P., Tweedy, L., and Insall, R.H. (2022). AKT and SGK kinases regulate cell migration by altering Scar\/WAVE complex activation and Arp2\/3 complex recruitment. Front. Mol. Biosci., 9.","DOI":"10.3389\/fmolb.2022.965921"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.7150\/ijbs.85986","article-title":"Coculture of cancer cells with platelets increases their survival and metastasis by activating the TGF\u03b2\/Smad\/PAI-1 and PI3K\/AKT pathways","volume":"19","author":"Tong","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.cellsig.2015.01.009","article-title":"A small molecule PAI-1 functional inhibitor attenuates neointimal hyperplasia and vascular smooth muscle cell survival by promoting PAI-1 cleavage","volume":"27","author":"Simone","year":"2015","journal-title":"Cell. Signal."},{"key":"ref_99","first-page":"85","article-title":"The SERPINE1\/LRP1 axis at the crossroads of downstream signaling to cell motility","volume":"13","author":"Czekay","year":"2018","journal-title":"Trends Cell Mol. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1074\/jbc.M313004200","article-title":"The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1","volume":"279","author":"Degryse","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"10375","DOI":"10.18632\/oncotarget.23735","article-title":"The crosstalk between breast carcinoma-associated fibroblasts and cancer cells promotes Rho A-dependent invasion via IGF and PAI-1","volume":"9","author":"Daubriac","year":"2017","journal-title":"Oncotarget"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.canlet.2018.10.027","article-title":"PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination","volume":"442","author":"Peng","year":"2019","journal-title":"Cancer Lett."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/15384047.2014.1001271","article-title":"Inhibition of plasminogen activator inhigitor-1 is a potential therapeutic strategy in ovarian cancer","volume":"16","author":"Mashiko","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"14308","DOI":"10.1074\/jbc.M109.046672","article-title":"Low density lipoprotein receptor-related protein 1 (LRP1) forms a signaling complex with platelet-derived growth factor receptor-beta in endosomes and regulates activationof the MAPK pathway","volume":"285","author":"Muratoglu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1172\/JCI28984","article-title":"PDGFRs are critical for PI3K\/Akt activation and negatively regulated by mTOR","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/hep.26384","article-title":"Platelet-derived growth factor-D and Rho GTPases regulate recruitment of cancer-associated fibroblasts in cholangiocarcinoma","volume":"58","author":"Cadamuro","year":"2013","journal-title":"Hepatology"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.3892\/mmr.2017.7641","article-title":"PDGF signaling pathway in hepatic fibrosis pathogenesis and therapeutics (review)","volume":"16","author":"Ying","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/j.1478-3231.2011.02687.x","article-title":"Targeting PDGFR-\u03b2 in cholangiocarcinoma","volume":"32","author":"Fingas","year":"2012","journal-title":"Liver Int."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00044-020-02694-2","article-title":"DDR1 and DDR2: A review on signaling pathway and small molecule inhibitors as an anticancer agent","volume":"30","author":"Matada","year":"2021","journal-title":"Med. Chem. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/s41388-022-02212-1","article-title":"DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF-6","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"Le, C.C., Bennasroune, A., Collin, G., Hachet, C., Lehrter, V., Rioult, D., Dedieu, S., Morgani, H., and Appert-Collin, A. (2020). LRP-1 promotes colon cancer cell proliferation in 3D collagen matrices by mediating DDR1 endocytosis. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.00412"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/jor.25594","article-title":"PAI-1 mediates TGF-\u03b21-induced myofibroblast activation in tenocytes via mTOR signaling","volume":"41","author":"Alenchery","year":"2023","journal-title":"J. Orthop. Res."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Omori, K., Hattori, N., Senoo, T., Takayama, Y., Masuda, T., Nakashima, T., Iwamoto, H., Fujitaka, K., Hamada, H., and Kohno, N. (2016). Inhibition of plasminogen activator inhibitor-1 attenuates transforming growth factor-\u03b2-dependent epithelial mesenchymal transition and differentiation of fibroblasts to myofibroblasts. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148969"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1167\/iovs.12-10042","article-title":"uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin","volume":"53","author":"Wang","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/wound.2014.0611","article-title":"Targeted inhibition of PAI-1 activity impairs epithelial migration and wound closure following cutaneous injury","volume":"4","author":"Simone","year":"2015","journal-title":"Adv. Wound Care"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ijo.2021.5239","article-title":"Cancer-associated fibroblast-induced M2-polarized macrophages promote hepatocellular carcinoma progression via the plasminogen activator inhibitor-1 pathway","volume":"59","author":"Chen","year":"2021","journal-title":"Int. J. Oncol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1007\/s13277-015-4629-y","article-title":"Secretome profiling of oral squamous ce;; carcinoma-associated fibroblasts reveals organization and disassembly of extracellular matrix and collagen metabolic process signatures","volume":"37","author":"Bagordakis","year":"2016","journal-title":"Tumour Biol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1111\/jcmm.14205","article-title":"Inhibition of PAI-1 limits chemotherapy resistance in lung cancer through suppressing myofibroblast characteristics of cancer-associated fibroblasts","volume":"23","author":"Masuda","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"ref_119","doi-asserted-by":"crossref","unstructured":"Wang, S., Pang, L., Liu, Z., and Meng, X. (2021). SERPINE1 associated with remodeling of the tumor microenvironment in colon cancer progression: A novel therapeutic target. BMC Cancer, 21.","DOI":"10.1186\/s12885-021-08536-7"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Yao, Q., Chen, W., Gao, F., Wu, Y., Zhou, L., Xu, H., Yu, J., Zhu, X., Wang, L., and Li, L. (2023). Characteristic analysis of featured genes associated with cholangiocarcinoma progression. Biomedicines, 11.","DOI":"10.3390\/biomedicines11030847"},{"key":"ref_121","first-page":"1641","article-title":"Single-cell transcriptomic analysis suggests two molecularly distinct subtypes of intrahepatic cholangiocarcinoma","volume":"13","author":"Song","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/hep.20903","article-title":"Transcriptional profiling after bile duct ligation identifies PAI-1 as a contributor to cholestatis injury in mice","volume":"42","author":"Wang","year":"2005","journal-title":"Hepatology"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nm0898-923","article-title":"Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization","volume":"4","author":"Bajou","year":"1998","journal-title":"Nat. Med."},{"key":"ref_124","first-page":"5839","article-title":"Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1","volume":"60","author":"Gutierrez","year":"2000","journal-title":"Cancer Res."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"33964","DOI":"10.1074\/jbc.M105980200","article-title":"Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis","volume":"276","author":"McMahon","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1074\/jbc.M007609200","article-title":"Inhibition of angiogenesis in vivo by plasminogen activator inhibitor-1","volume":"276","author":"Stefansson","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"40950","DOI":"10.1074\/jbc.M202333200","article-title":"Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells","volume":"277","author":"Palmieri","year":"2022","journal-title":"J. Biol. Chem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1242\/jcs.00051","article-title":"Epithelial monolayer wounding stimulates binding of USF-1 to an E-box motif in the plasminogen activator inhibitor type 1 gene","volume":"115","author":"Providence","year":"2022","journal-title":"J. Cell Sci."},{"key":"ref_129","first-page":"423","article-title":"Induction of apoptosis in vascular cells by plasminogen activator inhititor-1 and high molecular weight kininogen correlates with their anti-adhesive properties","volume":"384","author":"Chavakis","year":"2023","journal-title":"Biol. Chem."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"pe24","DOI":"10.1126\/stke.2003.189.pe24","article-title":"Old dogs and new tricks: Proteases, inhibitors, and cell migration","volume":"2003","author":"Stefansson","year":"2003","journal-title":"Sci. STKE"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/jcp.21806","article-title":"Plasminogen activator inhibitors regulate cell adhesion through a uPAR-dependent mechanism","volume":"220","author":"Czekay","year":"2009","journal-title":"J. Cell. Physiol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jcp.1133","article-title":"Plasminogen activator inhibitor-1 regulates cell adhesion by binding to the somatomedin B domain of vitronectin","volume":"189","author":"Deng","year":"2001","journal-title":"J. Cell. Physiol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1006\/excr.1997.3540","article-title":"Plaminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation","volume":"232","author":"Kjoller","year":"1997","journal-title":"Exp. Cell Res."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1699-0463.1999.tb01526.x","article-title":"Regulation of cell adhesion by PAI-1","volume":"107","author":"Loskutoff","year":"1999","journal-title":"APMIS"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Munoz-Galvan, S., Rivero, M., Peinado-Serrano, J., Martinez-Perez, J., Fernandez-Fernandez, M.C., Ortiz, M.J., Garcia-Heredia, J.M., and Carnero, A. (2020). PAI1 is a marker of bad prognosis in rectal cancer but predicts a better response to treatment with PIM inhibitor AZD1208. Cell, 9.","DOI":"10.3390\/cells9051071"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/(SICI)1097-0142(19991215)86:12<2602::AID-CNCR4>3.0.CO;2-S","article-title":"Larger and more invasive colorectal carcinoma contains larger amounts of plasminogen activator inhibitor type 1 and its relative ratio over urokinase receptor correlates well with tumor size","volume":"86","author":"Abe","year":"2000","journal-title":"Cancer"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0065-230X(08)61024-6","article-title":"Nonenzymatic interactions between proteinases and the cell surface: Novel roles in normal and malignant cell physiology","volume":"78","author":"Mignatti","year":"2000","journal-title":"Adv. Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj2570173","article-title":"Biochemical localization of the transformation-sensitive 52 kDa (p52) protein to the substratum contact regions of cultured rat fibroblasts","volume":"257","author":"Higgins","year":"1989","journal-title":"Biochem. J."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/S0021-9258(17)41995-8","article-title":"The somatomedin B domain of vitronectin. Structural requirements for the binding and stabilization of active type 1 plasminogen activator inhibitor","volume":"269","author":"Seiffert","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.1074\/jbc.272.12.7676","article-title":"Characterization of the binding of different conformational forms of plasminogen activator inhibitor-1 to vitronectin. Implications for the regulation of pericellular proteolysis","volume":"272","author":"Lawrence","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s000180050497","article-title":"The plasminogen activation system in tumor growth, invasion, and metastasis","volume":"57","author":"Andreasen","year":"2000","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1083\/jcb.200208117","article-title":"Plasminogen activator-1 detaches cells from extracellular matrices by inactivating integrins","volume":"160","author":"Czekay","year":"2003","journal-title":"J. Cell Biol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/jcp.1041530117","article-title":"Plasminogen activator inhibitor-1 is induced in migrating endothelial cells","volume":"153","author":"Pepper","year":"1992","journal-title":"J. Cell. Physiol."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0014-4827(92)90029-8","article-title":"The EFG-inducible protein EIP-1 of migrating normal and malignant rat liver epithelial cells is identical to plasminogen activator inhibitor 1 and is a component of the ECM migration tracks","volume":"202","author":"Seebacher","year":"1992","journal-title":"Exp. Cell Res."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00403-008-0845-2","article-title":"SERPINE1 (PAI-1) is deposited into keratinocyte migration \u201ctrails\u201d and required for optimal monolayer wound repair","volume":"300","author":"Providence","year":"2008","journal-title":"Arch. Dermatol. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1083\/jcb.111.5.2183","article-title":"Plasminogen activator inhibitor type 1 stabilizes vitronectin-dependent adhesions in HT-1080 cells","volume":"111","author":"Ciambrone","year":"1990","journal-title":"J. Cell Biol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.canlet.2011.01.018","article-title":"Molecular competition between plasminogen activator inhibitors type-1 and -2 for urokinase: Implications for cellular proteolysis and adhesion in cancer","volume":"303","author":"Lobov","year":"2011","journal-title":"Cancer Lett."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0955-0674(97)80126-3","article-title":"Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration","volume":"9","author":"Chapman","year":"1997","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"982","DOI":"10.15252\/embr.201541681","article-title":"Urokinase links plasminogen activation and cell adhesion by cleavage of the RGD motif in vitronectin","volume":"17","author":"Ferraris","year":"2016","journal-title":"Embo Rep."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<269::AID-JCP16>3.0.CO;2-E","article-title":"PAI-1 gene expression is regionally induced in wounded epithelial cell monolayers and required for injury repair","volume":"182","author":"Providence","year":"1995","journal-title":"J. Cell. Physiol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00001813-200401000-00007","article-title":"XR5967, a novel modulator of plasminogen activator inhibitor-1 activity, suppresses tumor cell invasion and angiogenesis in vitro","volume":"15","author":"Brooks","year":"2004","journal-title":"Anticancer Drugs"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-18-0836","article-title":"Plasminogen activator inhibitor 1 (PAI1) promotes actin cytoskeleton reogranization and glycolytic metabolism in triple-negative breast cancer","volume":"17","author":"Humphries","year":"2019","journal-title":"Mol. Cancer Res."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0002-9440(10)64367-2","article-title":"Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations","volume":"160","author":"Chazaud","year":"2002","journal-title":"Am. J. Pathol."},{"key":"ref_154","first-page":"447","article-title":"Cytoarchitectural analysis of epithelial sheets formed in vitro by hepatic tumor cells possessing defined intermediate-sized filament cytoskeletal abnormalities","volume":"134","author":"Ryan","year":"1989","journal-title":"Am. J. Path."},{"key":"ref_155","first-page":"530","article-title":"Keratin polypeptides in malignant epithelial liver tumors. Differential diagnostic and histologic aspects","volume":"127","author":"Fischer","year":"1987","journal-title":"Am. J. Path."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1042\/bj2840433","article-title":"Identification of the 52 kDa cytoskeletal-like protein of cytochalasin D-stimulated normal rat kidney (NRK\/CD) cells as substrate-associated glycoprotein p52 [plasminogen-activator inhibitor type-1 (PAI-1)]. Expression of p52 (PAI-1) in NRK\/CD cells is regulated at the level of mRNA abundance","volume":"284","author":"Higgins","year":"1992","journal-title":"Biochem. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1042\/bj3210431","article-title":"p52PAI-1 gene expression is butyrate-induced flat revertants of v-ras-transformed rat kidney cells: Mechanism of induction and involvement in the morphological response","volume":"321","author":"Higgins","year":"1997","journal-title":"Biochem. J."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","article-title":"Plasminogen activator inhibitor in cancer: Rationale and insight for future therapeutic testing","volume":"75","author":"Placencio","year":"2015","journal-title":"Cancer Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10555-019-09806-4","article-title":"The plasminogen activator inhibitor-1 paradox in cancer: A mechanistic understanding","volume":"38","author":"Kubala","year":"2019","journal-title":"Cancer Metast. Rev."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1093\/jnci\/djs377","article-title":"Protumorigenic activity of plasminogen activator inhibitor-1 through an antiapoptotic function","volume":"104","author":"Fang","year":"2012","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1158\/0008-5472.CAN-13-0661","article-title":"Targeting the tumor microenvironment: From understanding pathways to effective clinical trials","volume":"73","author":"Fang","year":"2013","journal-title":"Cancer Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3324\/haematol.2019.230227","article-title":"Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells","volume":"106","author":"Yahata","year":"2021","journal-title":"Haematologica"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1124\/jpet.105.095042","article-title":"Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis","volume":"316","author":"Bergheim","year":"2006","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1016\/j.febslet.2007.05.049","article-title":"Pai-1 deficiency reduces liver fibrosis after bile duct ligation in mice through activation of tPA","volume":"581","author":"Wang","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_165","first-page":"2948","article-title":"Novel oral plasminogen activator inhibitor-1 inhibitor TM5275 attenuates hepatic fibrosis under metabolic syndrome via suppression of activated hepatic stellate cells in rats","volume":"22","author":"Noguchi","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"ref_166","first-page":"221","article-title":"Plasminogen activator inhibitor-1 and oncogenesis in liver disease","volume":"2","author":"Nam","year":"2021","journal-title":"J. Cell. Signal."},{"key":"ref_167","first-page":"169","article-title":"The role of plasminogen activator inhibitor type-1 in fibrosis","volume":"143","author":"Flevaris","year":"2017","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00827.x","article-title":"Pleotropic functions of plasminogen activator inhibitor-1","volume":"3","author":"Lijnen","year":"2004","journal-title":"J. Thromb. Haemost."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/10\/796\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:41:17Z","timestamp":1760107277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/10\/796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":168,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["cells13100796"],"URL":"https:\/\/doi.org\/10.3390\/cells13100796","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,7]]}}}